Cameron Durrant
2020
In 2020, Cameron Durrant earned a total compensation of $2.4M as Chairman & Chief Executive Officer at KaloBios Pharmaceuticals, a 210% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,675,314 |
|---|---|
| Option Awards | $160,000 |
| Salary | $600,000 |
| Total | $2,435,314 |
Durrant received $1.7M in non-equity incentive plan, accounting for 69% of the total pay in 2020.
Durrant also received $160K in option awards and $600K in salary.
Rankings
In 2020, Cameron Durrant's compensation ranked 4,674th out of 13,090 executives tracked by ExecPay. In other words, Durrant earned more than 64.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,674 out of 13,090 | 64th |
Division Manufacturing | 1,899 out of 5,621 | 66th |
Major group Chemicals And Allied Products | 744 out of 2,254 | 67th |
Industry group Drugs | 638 out of 1,954 | 67th |
Industry Pharmaceutical Preparations | 482 out of 1,459 | 67th |
Source: SEC filing on April 23, 2021.
Durrant's colleagues
We found three more compensation records of executives who worked with Cameron Durrant at KaloBios Pharmaceuticals in 2020.